期刊文献+

PKM2基因在非小细胞肺癌中表达及其与放疗敏感性的关系 被引量:3

Expression of pyruvate kinase M2 in non-small cell lung cancer and its correlation with radiation sensitivity
下载PDF
导出
摘要 目的:研究PKM2在非小细胞肺癌组织中的表达及其与放疗敏感性的关系。方法:选取2011年5月至2013年10月四川省人民医院非小细胞肺癌120例患者,术后进行2个月的放射治疗,按照疗效将患者分为4组。RT-PCR检测患者放疗前手术切除的肿瘤组织和癌旁组织中PKM2 m RNA表达水平。Western blot和免疫组织化学检测肿瘤组织和癌旁组织中PKM2蛋白表达。RT-PCR和Western blot方法检测不同疗效组PKM2表达水平。结果:非小细胞肺癌放疗2个月后,治疗有效率为49.2%。PKM2在非小细胞肺癌癌组织中表达显著高于相应的癌旁组织。PKM2表达水平与患者放疗疗效呈负相关。结论:PKM2在非小细胞肺癌中表达高于癌旁组织,PKM2低表达患者对放疗敏感性高。 Objective: To investigate the expression level ofpyruvate kinase M2 (PKM2) in tissues of non-small cell lung cancer (NSCLC) patients and the correlation between PKM2 expression level and radiation sensitivity. Methods: A total of 45 NSCLC pa- tients were chosen and treated with radiotherapy for two months after surgery. The patients were classified into four groups based on the curative effect. The mRNA expression levels of PKM2 in tumor and the homologous paraneoplastic tissues of NSCLC patients were detected prior to radiotherapy using real time-polymerase chain reaction (RT-PCR), and the protein expressions of PKM2 in the tumor and paraneoplastic tissues of NSCLC patients were detected with Western blot analysis and immunohistochemical method. The mRNA and protein expression levels of PKM2 in the tumor tissues of different groups were detected with RT-PCR and Western blot assays. Results: The effective rate of radiotherapy for 2 months is 44.8% in NSCLC patients. The expression level of PKM2 is significantly higher in tumor tissues than in homologous paraneoplastic tissues of NSCLC patients and is negatively correlated with the curative effect of radiotherapy. Conclusion: The expression level of PKM2 is significantly higher in tumor tissues than in the paraneoplastic tissues of NSCLC patients. Patients with lower PKM2 expression level are more sensitive to radiotherapy.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2015年第8期421-425,共5页 Chinese Journal of Clinical Oncology
关键词 非小细胞肺癌 PKM2 放疗敏感性 non-small cell lung cancer, PKM2, radiation sensitivity
  • 相关文献

参考文献17

  • 1赵真真,王忠敏,茅爱武.非小细胞肺癌的介入治疗现状[J].介入放射学杂志,2014,23(3):272-276. 被引量:45
  • 2Komaki R,Tsao AS,Mehran RJ.Non-Small Cell Lung Cancer[M].Springer New York,2013:45-62.
  • 3钟幸,王瑾.EGFR突变与非小细胞肺癌放射治疗进展[J].中国肺癌杂志,2013,16(3):157-161. 被引量:5
  • 4Bradley JD,Paulus R,Komaki R,et al.A randomized phase III comparison of standard-dose(60 Gy)versus high-dose(74 Gy)conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer:Results on radiation dose in RTOG 0617[J].J Clin Oncol,2013,31(15):7501.
  • 5Wang XC,Du LQ,Tian LL,et al.Expression and function of mi RNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer[J].Lung Cancer,2011,72(1):92-99.
  • 6尹晨希,周菲菲,夏良平.恶性肿瘤患者血清中PKM2水平的诊断和预后预测价值[J].肿瘤学杂志,2013,19(7):565-569. 被引量:3
  • 7Martinez-Balibrea E,Plasencia C,Ginés A,et al.A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines[J].Molecular Cancer Therapeutics,2009,8(4):771-778.
  • 8Shi HS,Li D,Zhang HL,et al.Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice[J].Cancer Science,2010,101(6):1447-1453.
  • 9Papadaki C,Sfakianaki M,Lagoudaki E,et al.PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer[J].Br J Cancer,2014,111(9):1757-1764.
  • 10Chaneton B,Gottlieb E."Rocking cell metabolism:revised functions of the key glycolytic regulator PKM2 in cancer[J].Trends Biochemi Sci,2012,37(8):309-316.

二级参考文献69

共引文献74

同被引文献37

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部